Bharat Immunologicals (India) Risk Analysis

Bharat Immunologicals Biologicals Corp Ltd -- India Stock  

INR 21.3  0.1  0.47%

Macroaxis considers Bharat Immunologicals to be not very risky. Bharat Immunologicals secures Sharpe Ratio (or Efficiency) of -0.0824 which signifies that Bharat Immunologicals had -0.0824% of return per unit of standard deviation over the last 1 month. Macroaxis philosophy in foreseeing risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. Bharat Immunologicals Biologicals Corp Ltd exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Bharat Immunologicals Mean Deviation of 1.35 and Risk Adjusted Performance of (0.034712) to double-check risk estimate we provide.
Investment Horizon     30 Days    Login   to change

Bharat Immunologicals Market Sensitivity

As returns on market increase, returns on owning Bharat Immunologicals are expected to decrease at a much smaller rate. During bear market, Bharat Immunologicals is likely to outperform the market.
One Month Beta |Analyze Bharat Immunologicals Demand Trend
Check current 30 days Bharat Immunologicals correlation with market (DOW)
β = -0.069
Bharat Immunologicals Almost negative betaBharat Immunologicals Beta Legend

Bharat Immunologicals Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of seventeen. Bharat Immunologicals Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input. View also all equity analysis or get more info about average price price transform indicator.

Projected Return Density Against Market

Assuming 30 trading days horizon, Bharat Immunologicals Biologicals Corp Ltd has beta of -0.069 . This suggests as returns on benchmark increase, returns on holding Bharat Immunologicals are expected to decrease at a much smaller rate. During bear market, however, Bharat Immunologicals Biologicals Corp Ltd is likely to outperform the market. Additionally, Bharat Immunologicals Biologicals Corp Ltd has a negative alpha implying that the risk taken by holding this equity is not justified. The company is significantly underperforming DOW
 Predicted Return Density 
      Returns 
Assuming 30 trading days horizon, the coefficient of variation of Bharat Immunologicals is -1214.23. The daily returns are destributed with a variance of 4.1 and standard deviation of 2.03. The mean deviation of Bharat Immunologicals Biologicals Corp Ltd is currently at 1.35. For similar time horizon, the selected benchmark (DOW) has volatility of 0.39
α
Alpha over DOW
=0.23
βBeta against DOW=0.07
σ
Overall volatility
=2.03
 IrInformation ratio =0.13

Actual Return Volatility

Bharat Immunologicals Biologicals Corp Ltd accepts 2.0256% volatility on return distribution over the 30 days horizon. DOW inherits 0.3614% risk (volatility on return distribution) over the 30 days horizon.
 Performance (%) 
      Timeline 

Market Risk Breakdown

Bharat Immunologicals Volatility Factors

30 Days Market Risk

Not very risky

Chance of Distress in 24 months

Below average

30 Days Economic Sensitivity

Indifferent to market move

Largest Trends

Bharat Immunologicals Largest Period Trend

Investment Outlook

Bharat Immunologicals Investment Opportunity
Bharat Immunologicals Biologicals Corp Ltd has a volatility of 2.03 and is 5.64 times more volatile than DOW. 18% of all equities and portfolios are less risky than Bharat Immunologicals. Compared to the overall equity markets, volatility of historical daily returns of Bharat Immunologicals Biologicals Corp Ltd is lower than 18 (%) of all global equities and portfolios over the last 30 days. Use Bharat Immunologicals Biologicals Corp Ltd to protect against small markets fluctuations. The stock experiences normal downward trend and little activity. Check odds of Bharat Immunologicals to be traded at 21.09 in 30 days. As returns on market increase, returns on owning Bharat Immunologicals are expected to decrease at a much smaller rate. During bear market, Bharat Immunologicals is likely to outperform the market.

Bharat Immunologicals correlation with market

Good diversification
Overlapping area represents the amount of risk that can be diversified away by holding Bharat Immunologicals Biologic and equity matching DJI index in the same portfolio.

Volatility Indicators

Bharat Immunologicals Current Risk Indicators